loading
Schlusskurs vom Vortag:
$3.65
Offen:
$3.5675
24-Stunden-Volumen:
1,367
Relative Volume:
0.15
Marktkapitalisierung:
$147.37M
Einnahmen:
$7.80M
Nettoeinkommen (Verlust:
$-69.02M
KGV:
-1.7046
EPS:
-2.1413
Netto-Cashflow:
$-66.61M
1W Leistung:
+2.81%
1M Leistung:
-2.93%
6M Leistung:
-34.29%
1J Leistung:
-44.02%
1-Tages-Spanne:
Value
$3.5675
$3.66
1-Wochen-Bereich:
Value
$3.51
$3.70
52-Wochen-Spanne:
Value
$3.36
$12.22

Molecular Partners Ag Adr Stock (MOLN) Company Profile

Name
Firmenname
Molecular Partners Ag Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
159
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-26
Name
Neueste SEC-Einreichungen
Name
MOLN's Discussions on Twitter

Vergleichen Sie MOLN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MOLN
Molecular Partners Ag Adr
3.65 130.91M 7.80M -69.02M -66.61M -2.1413
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.27 123.14B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
550.00 60.43B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.69 42.07B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
572.71 34.47B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
290.35 27.42B 3.81B -644.79M -669.77M -6.24

Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-08-30 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2022-08-29 Herabstufung SVB Leerink Outperform → Mkt Perform
2022-05-25 Hochstufung Credit Suisse Underperform → Neutral
2022-04-27 Herabstufung Credit Suisse Neutral → Underperform
2021-07-13 Eingeleitet Cowen Outperform
2021-07-12 Fortgesetzt SVB Leerink Outperform
Alle ansehen

Molecular Partners Ag Adr Aktie (MOLN) Neueste Nachrichten

pulisher
Jul 02, 2025

Molecular Partners (NASDAQ:MOLN) Stock Price Down 3.4% – Should You Sell? - Defense World

Jul 02, 2025
pulisher
Jun 11, 2025

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025 - GlobeNewswire Inc.

Jun 11, 2025
pulisher
May 14, 2025

Walmart, Deere, Applied Materials set to report earnings Thursday By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Walmart, Deere, Applied Materials set to report earnings Thursday - Investing.com

May 14, 2025
pulisher
Apr 26, 2025

Ziff Davis Inc (NASDAQ:ZD) Shares Jumped 1.54% In A Week. Can It Continue Rising? - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 25, 2025

Molecular Partners' AACR 2025 Breakthroughs: Radio-DARPins and Smart T Cell Engagers Ignite Oncology Potential - AInvest

Apr 25, 2025
pulisher
Apr 03, 2025

Can Contango ORE, Inc. (CTGO) Climb 163.28% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Musk's DOGE Exit Rumors & Weak Q1 Deliveries: How to Play Tesla Now - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Why Tractor Supply (TSCO) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Apr 03, 2025
pulisher
Mar 14, 2025

TD Cowen maintains Buy on Molecular Partners, target CHF15 - Investing.com India

Mar 14, 2025
pulisher
Mar 06, 2025

Molecular Partners reports 2024 annual results - Investing.com India

Mar 06, 2025
pulisher
Dec 13, 2024

Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance

Dec 13, 2024
pulisher
Oct 22, 2024

Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks

Oct 22, 2024
pulisher
Apr 24, 2022

US stock market gainers for the last week of April 2022 - Nairametrics

Apr 24, 2022
pulisher
Jan 10, 2022

Novartis to push forward with covid drug after positive results - Luxembourg Times

Jan 10, 2022
pulisher
Jan 06, 2022

Wall Street Analysts See a 96% Upside in Molecular Partners AG Sponsored ADR (MOLN): Can the Stock Really Move This High? - Yahoo Finance

Jan 06, 2022
pulisher
Jun 21, 2021

Citi Appointed as Depositary Bank for Molecular Partners AG’s ADR Programme - Business Wire

Jun 21, 2021

Finanzdaten der Molecular Partners Ag Adr-Aktie (MOLN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$22.01
price up icon 0.64%
$35.47
price down icon 0.37%
$104.17
price down icon 0.40%
$27.63
price down icon 2.26%
$111.04
price down icon 1.29%
biotechnology ONC
$290.35
price up icon 4.01%
Kapitalisierung:     |  Volumen (24h):